Strip of 15 Units
Old MRP ₹207.75
MRP ₹194.77
₹155.82
₹12.98/Units
Use current location
Login to view saved addresses
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Below 30o C
Amtas-M-25 Tablet is a combination cardiovascular medicine used primarily to manage hypertension (high blood pressure) and angina pectoris (chest pain). It combines amlodipine (CCB) and metoprolol (Beta-Blocker). It is also useful in the management of coronary heart disease, regulating heart and blood vessel issues by relaxing blood vessels and reducing heart rate.
Amtas-M-25 Tablet is used for managing high blood pressure or hypertension. It helps in managing chest pain due to heart-related issues, known as angina pectoris. It is also prescribed for managing a heart condition where the blood vessels supplying the heart become narrow, called coronary heart disease.
Here are some guidelines on how to take Amtas-M-25 Tablet:
Follow the dosage and timing instructions provided by your doctor precisely.
Do not change or exceed the prescribed dose without consulting your doctor.
Consult your doctor before discontinuing the medication; do not stop taking it without their guidance.
Adhere to the dietary recommendations given by your doctor.
Amtas-M-25 Tablet is taken orally.
Amtas-M-25 Tablet may cause side effects such as dizziness, fatigue, headache, nausea, abdominal pain, constipation, bradycardia (slow heart rate), or peripheral oedema (swelling of ankles and feet). If these persist, consult your doctor.
Most side effects are temporary and generally harmless, which resolve on discontinuing the use of Amtas-M-25 Tablet. However, if you experience any serious side effects or worsening of any of the symptoms, please consult your doctor.
Here are some general guidelines for managing common side effects:
Nausea: Follow the dietary recommendations provided by your doctor.
Abdominal pain: If you experience stomach discomfort, stay away from very heavy meals and junk food for a few days.
Amtas-M-25 Tablet contains two active ingredients:
Amlodipine (5 mg): This component belongs to the dihydropyridine class of calcium channel blockers. It works by relaxing the smooth muscles in your blood vessels. This reduces peripheral vascular resistance and consequently lowers your blood pressure.
Metoprolol Succinate (25 mg): This ingredient is a beta1-selective adrenoceptor blocking agent. By blocking these receptors in your heart and vascular smooth muscle, it reduces your heart rate and strain on your heart. This leads to a decrease in blood pressure and alleviates chest pain due to its cardio-protective properties.
Caution is advised while taking Amtas-M-25 Tablet if you are pregnant. It is best to consult your doctor before taking this medicine.
Consult your doctor before taking this medication if you are breastfeeding.
It is advisable to discuss this with your doctor before consuming alcohol while on this medication.
If you have liver problems, discuss them with your doctor before starting Amtas-M-25 Tablet. This medicine may affect liver function, especially in severe liver diseases.
Caution is advised before using Amtas-M-25 Tablet if you have a history of any kidney problems. It is a good idea to consult your doctor before taking this medicine.
Amtas-M-25 Tablet may cause dizziness or fatigue. If you experience these side effects, avoid driving or operating heavy machinery until you feel better or as advised by your doctor.
This medicine should not be taken if you have known allergies to Amlodipine, Metoprolol Succinate, or any other ingredients in the tablet. If you experience any allergic reactions, seek immediate medical attention.
Amtas-M-25 Tablet should not be given to children under 18 years of age unless prescribed by a doctor. Always consult your doctor before giving any medicine to a child.
Older patients should take Amtas-M-25 Tablet under medical supervision as they may be more susceptible to its side effects. Caution is advised if patients are above 70 years of age. Your doctor will guide you based on your health status.
Amtas-M-25 Tablet interacts with the following medicines:
CYP2D6 inhibitors: Medicines like quinidine, fluoxetine, and paroxetine can affect how Amtas-M-25 Tablet works in your body. These inhibitors can slow down the breakdown of metoprolol succinate, potentially increasing its effects.
CYP3A4 inhibitors: Ketoconazole, itraconazole, and ritonavir may interfere with amlodipine's breakdown in your body. This can increase amlodipine levels and lead to more pronounced effects.
CYP3A4 inducers: Medicines such as rifampin, phenytoin, and phenobarbital might decrease amlodipine's concentration in your body, reducing its effect.
Specific interactions with food have not been reported for this medicine.
Amtas-M-25 Tablet interacts with the following diseases:
Peripheral vascular disease: The medicine may cause more pronounced blood pressure lowering in patients with this condition.
Diabetes mellitus: Amtas-M-25 Tablet could affect blood sugar levels, requiring adjustments in your diabetic medications.
Thyrotoxicosis: This thyroid disease could increase the risk of heart-related side effects from the medicine.
Bronchospastic diseases: If you have bronchospastic diseases like asthma or COPD, use of metoprolol succinate may worsen your condition.
Your daily dose of Amtas-M-25 Tablet should be as your doctor prescribes. This dosage may vary based on your individual condition and response to the medicine. Always follow your doctor's instructions and never alter your dosage without discussing it with them first.
If you accidentally take more than the prescribed dose of Amtas-M-25 Tablet, you might experience common side effects like dizziness or fatigue. If these symptoms persist, please consult your doctor.
If you forget to take a dose of Amtas-M-25 Tablet, take it as soon as you remember. If it's almost time for your next dose, skip the missed one and continue with your regular schedule. Always consult your doctor before making any changes to the dosing schedule.
Store Amtas-M-25 Tablet in a tightly sealed container.
Keep it at room temperature.
Avoid exposure to excess light and moisture.
Make sure to keep this medicine out of the reach of children.
Always check the expiry date before use and discard if past this date.
Since Amtas-M-25 Tablet is used to manage high blood pressure, reducing your salt intake can help. Aim to eat less processed and fast food, which often contain hidden salts.
Incorporate regular exercise into your daily routine. Even light activities like walking or cycling can help manage blood pressure and heart condition. However, always consult your doctor before starting any new exercise regime.
| Available Dosage Types | Tablet |
| Habit Forming | No |
| Ailment | Hypertension, Angina Pectoris, Coronary Heart Disease |
| Drug Category | Calcium Channel Blocker, Beta1-Selective Adrenoceptor Blocking Agent |
| Therapeutic Category | Antihypertensive |
Amtas-M-25 Tablet is used to manage high blood pressure, chest pain, and coronary heart disease.
Amtas-M-25 Tablet reduces blood pressure and heart strain by relaxing blood vessels and slowing the heart rate.
No, you should not stop taking this medicine without consulting your doctor as it could worsen your condition.
If you miss a dose, take it as soon as you remember unless it's nearly time for the next dose.
Consult your doctor before taking this medication under these circumstances.
The onset of action varies among individuals. Consistent use over days or weeks may be needed to see full effects.
Common side effects include dizziness, fatigue, nausea, and a slow heart rate. Report severe or persistent side effects to your doctor immediately.
Check out Editorial Policy
Novartis Pharmaceuticals Corporation. (2003). LOPRESSOR (metoprolol tartrate) tablet. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/017963s062,018704s021lbl.pdf
DailyMed. (n.d.). DailyMed - METOPROLOL SUCCINATE tablet, extended release. Retrieved 1 April 2024, from https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=a8374722-d2b5-4eb3-bbcd-6ddc52e763ba&type=display
Pfizer. (1987). NORVASC [Prescribing Information]. In NORVASC (pp. 1–7). https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019787s047lbl.pdf
DailyMed - AMLODIPINE- amlodipine besylate tablet. (n.d.). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b52e2905-f906-4c46-bb24-2c7754c5d75b
Biocon. (n.d.). COMPOSITION - Actiblock AM 25/50. https://www.biocon.com/docs/prescribing_information/cardiology/actiblockam_pi.pdf
Moodahadu, L., Rao, N., Oomman, A., Bindumathi, P., Sharma, V., Rao, S., Patnaik, A., & Kumar, B. R. (2013). Efficacy and tolerability of fixed dose combination of metoprolol and amlodipine in Indian patients with essential hypertension. Journal of Mid-life Health, 4(3), 160. https://doi.org/10.4103/0976-7800.119000
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
62.45% CHEAPER
7403 users bought this instead
Read More
...View more
...View more
...View more
Company
About UsHealth ArticleHealth StoriesDiseases & Health ConditionsAyurvedaAll MedicinesAll BrandsNeed HelpFAQSecuritySubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.8.1
2025 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
Composition
